Subject
Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology,Hematology,General Medicine
Reference22 articles.
1. Predicting survival and leukemic evolution in patients with myelodysplastic syndrome;Malcovati;Haematologica,2006
2. Does iron chelation therapy improve survival in regularly transfused lower risk MDS patients? A multicenter study by the GFM (Groupe francophone des myélodysplasies);Christian Rose 1;Leuk Res,2010
3. Labile plasma iron levels predict survival in patients with lower-risk myelodysplastic syndromes;de Swart;Haematologica,2018
4. Transfusion dependency is associated with presence of toxic iron species and inferior survival in patients with lowerrisk myelodysplastic syndromes;Hoeks,2019
5. Do recent randomized trial results influence which patients with myelodysplastic syndromes receive iron chelation?;Gattermann;Hematol Oncol Clin North Am,2020